Lexi-Comp
For healthcare professionals including pharmacists, physicians, and nurses requiring real-time drug interaction and safety data.
UpToDate Lexidrug
Snapshot
Who is Lexi-Comp?
Providing healthcare professionals with evidence-based drug information and clinical decision support tools at the point of care.
Target audience
Portfolio
Free 1Last updated
UpToDate Lexidrug
vVARY
4mo ago
Publisher DNA
What defines Lexi-Comp?
Publisher DNA
Primary focus
Clinical decision support and medical reference tools
Scale
indie
Target audience
Healthcare professionals including pharmacists, physicians, and nurses requiring real-time drug interaction and safety data.
Origin
A brand under Wolters Kluwer, a global provider of professional information, software solutions, and services for the healthcare and financial sectors.
Signature Patterns
- •Subscription-based monetization model with professional-tier pricing ($29.99/month)
- •Focus on high-utility clinical features including interaction checkers and medical calculators
- •Frequent update cadence to maintain accuracy of evidence-based medical databases
- •Professional-grade interface designed for high-stakes clinical environments
Portfolio momentum
Maintained a consistent development cycle with 4 releases in the last 6 months, including a major update to their flagship title within the last 3 days.
Portfolio
What does Lexi-Comp ship?
Apps
1 app analysed
UpToDate Lexidrug (formerly Lexicomp), drug monographs, interactions & more
Offline database access creates high switching costs
- Reliable clinical reference content remains a daily essential for medical professionals in clinical settings
- Persistent database download failures prevent access to critical drug interactions and compatibility information
Distributed across 9 markets, strongest in Europe.
Based on 1 of 1 app with localized market data · last scanned .
Americas (3)
- Brazil1 / 1
- Mexico1 / 1
- United States1 / 1
Europe (5)
- France1 / 1
- Germany1 / 1
- Italy1 / 1
- Portugal1 / 1
- Spain1 / 1
Asia-Pacific (1)
- Japan1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
1
Negative apps
25/100
Avg sentiment score
Rivals
Who does Lexi-Comp compete with?
The rivals identified
Nemeses(1)
With over 36,000 reviews and a high-velocity release cadence, this app dominates the general-purpose drug reference market.
Contenders(2)
Highly specialized niche leader with strong professional loyalty and consistent update velocity.
A trusted, authoritative brand that provides high-quality clinical content for medical professionals.
Same space(4)
A direct competitor in the clinical decision support space, focusing on evidence-based medicine.
A social-professional network that provides clinical context through shared medical cases.
A legacy professional drug reference tool that competes directly for the clinical audience.
Adjacent toolset focusing on clinical calculators rather than drug monographs.
The Analyst's Read
The bottom line on Lexi-Comp
Bottom line
Lexi-Comp is a specialized enterprise medical publisher leveraging the Wolters Kluwer ecosystem to maintain a dominant position in clinical drug reference. Their disciplined update cycle and high-friction subscription model reflect a strategic focus on institutional reliability and professional utility over mass-market consumer reach.
Frequently asked questions
How many apps does Lexi-Comp publish?
What kind of apps does Lexi-Comp make?
What is Lexi-Comp's top app?
In how many countries are Lexi-Comp's apps available?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 1
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- yes